Alan A. Steigrod
Corporate Officer/Principal presso Newport Health Care Ventures
Posizioni attive di Alan A. Steigrod
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| Newport Health Care Ventures | Corporate Officer/Principal | 01/01/1996 | - |
Storia della carriera di Alan A. Steigrod
Precedenti posizioni note di Alan A. Steigrod
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 1984 and is headquartered in Marlborough, MA. | Direttore/Membro del Consiglio | 01/01/1995 | 20/10/2009 |
Cellegy Pharmaceuticals, Inc.
 Cellegy Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cellegy Pharmaceuticals specialty biopharmaceutical company, that is primarily engaged in the development and commercialization of prescription drugs targeting women’s health care, including reduction in transmission of HIV and female sexual dysfunction, and gastrointestinal conditions using proprietary topical formulations and nitric oxide, or NO, donor technologies | Direttore/Membro del Consiglio | - | 22/04/2009 |
| PONIARD PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | - | 16/08/2006 |
| RESPIRERX PHARMACEUTICALS INC. | Presidente | 01/03/1993 | 01/11/1995 |
| Alan Steigrod Consulting | Presidente | 01/02/1991 | 01/02/1993 |
| Glaxo, Inc. | Vendite & Marketing | 01/03/1981 | 01/02/1991 |
| APTOSE BIOSCIENCES INC. | Direttore/Membro del Consiglio | 01/05/2001 | - |
Statistiche
Distribuzione geografica
| Stati Uniti | 7 |
| Canada | 3 |
Posizioni
| Director/Board Member | 4 |
| President | 2 |
| Corporate Officer/Principal | 1 |
Settori
| Health Technology | 6 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| PONIARD PHARMACEUTICALS, INC. | Health Technology |
| APTOSE BIOSCIENCES INC. | Health Technology |
| RESPIRERX PHARMACEUTICALS INC. | Health Technology |
| Aziende private | 5 |
|---|---|
Cellegy Pharmaceuticals, Inc.
Cellegy Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cellegy Pharmaceuticals specialty biopharmaceutical company, that is primarily engaged in the development and commercialization of prescription drugs targeting women’s health care, including reduction in transmission of HIV and female sexual dysfunction, and gastrointestinal conditions using proprietary topical formulations and nitric oxide, or NO, donor technologies | Health Technology |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 1984 and is headquartered in Marlborough, MA. | Health Technology |
| Newport Health Care Ventures | |
| Glaxo, Inc. | |
| Alan Steigrod Consulting |
- Borsa valori
- Insiders
- Alan A. Steigrod
- Esperienza
